Peter Bohus
Kosice, KI 04011, Slovakia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Atherosclerosis: A Pathologist's Perspective.
Journal: Journal of cardiovascular development and disease
Published: December 02, 2025
Left atrial primary intimal sarcoma mimicking myxoma: case report.
Journal: European heart journal. Case reports
Published: October 20, 2025
MMP7 as a prospective marker of pancreatic carcinoma.
Journal: Updates in surgery
Published: June 02, 2025
Primary cardiac lymphoma: autopsy case report and literature review.
Journal: Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie
Published: May 19, 2025
Alveolar Bile and Light Chain Immunoglobulin Depositions as an Unusual Complication of Transjugular Liver Biopsy Resulting in Bilhemia in a Patient with Multiple Myeloma.
Journal: Journal of clinical medicine
Published: February 07, 2025
Validation of Lipophosphonoxin-loaded Polycaprolactone Nanofiber Dressing for Full-thickness Wounds in a Porcine Model.
Journal: In vivo (Athens, Greece)
Published: December 29, 2024
Oxidative stress and PARP activation in the lungs is an early event in COVID-19 pneumonia.
Journal: Free radical biology & medicine
Published: October 28, 2024
Assessment of Agrimonia eupatoria L. and Lipophosphonoxin (DR-6180) Combination for Wound Repair: Bridging the Gap Between Phytomedicine and Organic Chemistry.
Journal: Biomolecules
Published: October 21, 2024
Gyrophoric Acid, a Secondary Metabolite of Lichens, Exhibits Antidepressant and Anxiolytic Activity In Vivo in Wistar Rats.
Journal: International journal of molecular sciences
Published: September 29, 2024
First documented case of visceral leishmaniasis with rare colonic involvement in an immunocompetent adult in Slovakia.
Journal: BMC infectious diseases
Published: September 03, 2024
Expression of individual members of the TGF-β/SMAD signalling pathway in the progression and survival of patients with colorectal carcinoma.
Journal: Scientific reports
Published: March 18, 2024
The PARP inhibitor rucaparib blocks SARS-CoV-2 virus binding to cells and the immune reaction in models of COVID-19.
Journal: British journal of pharmacology
Published: September 15, 2023
Last Updated: 09/26/2026